SC16 will continue its HPC Matters Plenary session series this year with a panel discussion on HPC and Precision Medicine. The event will take place at 5:30 pm on Monday, Nov 14 just prior to the exhibits opening gala.
Leading voices from the frontlines of clinical care, medical research, public policy and pharmaceutical R&D will share diverse perspectives on the future of precision medicine. Emerging technology is transforming the practice of medicine from an analog field of paper notebooks, textbooks and charts into a digital domain. This transition may emerge as one the most fundamental important tipping points since the discovery of penicillin, molecular biology, and the sequencing of the human genome. Recently, DOE Secretary Moniz, VA Secretary MacDonald, NCI Director Lowy and the GSK CEO Andrew Witty announced that the Nation’s leading supercomputers would be applied to the challenge of the Cancer Moonshot initiative. This partnership of nontraditional groups, collectively see the path to unraveling the complexities of cancer through the power of new machines, operating systems, and applications that leverage simulations, data science and artificial intelligence to accelerate bringing precision oncology to the patients that are waiting. This initiative is one of many research efforts in the race to solve some of our most challenging medical problems.
SC16 Invited Panelists:
- Dr. Timothy Buchman, Emory University: Professor of Surgery, Emory University School of Medicine; Professor of Anesthesiology, Emory University School of Medicine; Director, Emory Critical Care Center, Emory University School of Medicine; Chief, Critical Care Service, Emory Healthcare
- Dr. Mitchell Cohen, Director of Surgery, Denver Health Medical Center; Professor, University of Colorado School of Medicine. Cohen’s research portfolio includes research funded by the U.S. Department of Defense, the Patient-Centered Outcomes Research Institute, and the National Institutes of Health.
- Dr. Dimitri Kusnezov, Chief Scientist & Senior Advisor to the Secretary, U.S. Department of Energy, National Nuclear Security Administration
- Dr. Martha Head, Senior Director, The Noldor; Acting Head, Insights from Data at GlaxoSmithKline Pharmaceuticals
In this HPC Matters video, Kathleen Nicol, pediatric cancer researcher and Vice Chair of Clinical Labs at Nationwide Children’s Hospital discusses the importance of HPC to her work and its impact on pediatric cancer research. Kathleen is using HPC Systems at the Ohio Supercomputer Center everyday to make the world a better place. Find out how.
The annual Supercomputing Conference (SC) is the foremost academic event that brings together thousands of the world’s leading computer scientists who must develop the technology to make these breakthroughs possible.
Registration is now open for SC16, which takes place Nov. 13-18 in Salt Lake City.